InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,715.84
(
1.31%
)
Post# of 2338175
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

budfoxfun

Send PM Follow Ignore
Followers 971
Posts 382998
Boards Moderated 6
Alias Born 06/24/2011

budfoxfun

Re: None

Tuesday, 04/16/2024 8:56:45 AM

Tuesday, April 16, 2024 8:56:45 AM

Post# of 2338175
$NBIO a clinical-stage biotechnology Company developing monoclonal antibodies targeting various cancer types, announces that it is embarking on a fresh manufacturing run to ensure Pritumumab ("PTB") supplies are at maximum potency when patient dosing begins in the upcoming Phase II clinical trial. Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Run https://finance.yahoo.com/news/nascent-prepares-pivotal-phase-ii-120000620.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up